The role of interferon regulatory factors in atherosclerosis
Authors:
Open Access
- 4 September 2025
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 12, 1606034
Abstract
Cardiovascular diseases (CVDs) remain a leading cause of global morbidity and mortality, largely driven by the progression of atherosclerotic plaques. In atherosclerosis (AS), transcription factors and epigenetic mechanisms play pivotal roles in regulating gene expression. Interferon regulatory factors (IRFs), a family of transcription factors initially identified for their role in coordinating interferon (IFN) responses, are now recognized as critical modulators of innate and adaptive immunity. Emerging evidences highlights their involvement in inflammation, lipid metabolism, cell differentiation, cell proliferation, and programmed cell death during AS pathogenesis. This review synthesizes current knowledge on the roles and regulatory mechanisms of IRFs in AS, offering novel insights and potential therapeutic targets for AS management.Keywords
This publication has 105 references indexed in Scilit:
- IRF-1 Regulates Mitochondrial Respiration and Intrinsic Apoptosis Under Metabolic Stress through ATP Synthase Ancillary Factor TMEM70Inflammation, 2024
- IL-33 Suppresses the Progression of Atherosclerosis via the ERK1/2-IRF1-VCAM-1 PathwayCardiovascular Drugs and Therapy, 2023
- KPNA2 Silencing, Regulated by E3 Ubiquitin Ligase FBXW7, Alleviates Endothelial Dysfunction and Inflammation Through Inhibiting the Nuclear Translocation of p65 and IRF3: A Possible Therapeutic Approach for AtherosclerosisInflammation, 2023
- An update on the phenotypic switching of vascular smooth muscle cells in the pathogenesis of atherosclerosisCellular and Molecular Life Sciences, 2021
- The Transcription Factor SUB1 Is a Master Regulator of the Macrophage TLR Response in AtherosclerosisAdvanced Science, 2021
- IRF4 at the crossroads of effector T‐cell fate decisionEuropean Journal of Immunology, 2014
- Interferon Regulatory Factor 9 Protects Against Hepatic Insulin Resistance and Steatosis in Male MiceHepatology, 2013
- Interferon regulatory factor 3 is a negative regulator of pathological cardiac hypertrophyBasic Research in Cardiology, 2013
- Inhibition of IFN Regulatory Factor-1 Down-Regulate Th1 Cell Function in Patients with Acute Coronary SyndromeJournal of Clinical Immunology, 2010
- The activation of liver X receptors inhibits toll‐like receptor‐9‐induced foam cell formationJournal of Cellular Physiology, 2010